As CD8+ T cell-mediated killing of MHC-I-negative tumors in our models was likewise dependent on TCR activation but did not require antigen-cognate interactions between T cells and tumor cells, we hypothesized that NKG2D might be an important contributor to the tumoricidal mechanism. Here, CD8A is linked to neoplasm.